The Optispan Podcast with Matt Kaeberlein cover image

The Optispan Podcast with Matt Kaeberlein

Brain Aging & Alzheimer’s Prevention: The Future of Cognitive Health Testing | Dr. Christin Glorioso | 106

Mar 18, 2025
Dr. Christin Glorioso, founder of NeuroAge Therapeutics, dives into the cutting-edge landscape of brain aging and Alzheimer’s prevention. Discover how innovative tests predict Alzheimer’s risk decades ahead, combining genetic insights with lifestyle choices. Glorioso discusses the power of diet, exercise, and sleep on cognitive health, alongside the latest advancements in medications like GLP-1 agonists. Plus, learn about the fascinating role of MRI scans and neural games in assessing brain health, making a compelling case for the future of cognitive well-being.
01:00:35

Podcast summary created with Snipd AI

Quick takeaways

  • NeuroAge Therapeutics utilizes advanced brain age testing combining MRI, cognitive assessments, blood biomarkers, and genetics to predict Alzheimer's risk early on.
  • About 40% of brain aging is influenced by lifestyle choices like diet and exercise, emphasizing actionable habits for cognitive health.

Deep dives

Understanding NeuroAge Therapeutics

NeuroAge Therapeutics focuses on assessing brain aging and future Alzheimer's risk through a comprehensive testing platform. This platform combines brain MRI, cognitive assessments, blood biomarkers, and genetic testing to generate a single score known as neuro age. Approximately 40% of brain aging is linked to lifestyle choices, emphasizing the significance of actionable recommendations to slow down cognitive decline. Personalized strategies are offered to help individuals mitigate their risk and enhance brain health proactively.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner